Use of Psychotropic Medication in the General Population of France, Germany, Italy, and the United Kingdom
The DOI matches its Crossref record.
Abstract
BACKGROUND: The use of psychotropic medications and its association with sleep and psychiatric and physical illnesses were studied in the general population. METHOD: A cross-sectional telephone survey was carried out using the Sleep-EVAL knowledge-base system. A representative sample of the noninstitutionalized general populations of France, Germany, Italy, and the United Kingdom, aged 15 years or over, was interviewed (N = 18,679; participation rate: 78.8%; target population: 204,605,391 inhabitants). Questions were asked about psychotropic medication intake (name of medication, indication, dosage, duration of intake, prescriber), sociodemographics, physical illnesses, and DSM-IV mental disorders. RESULTS: At the time of the interview, 6.4% of the subjects took a psychotropic medication. Anxiolytics were reported by 4.3% of the sample, hypnotics by 1.5%, antidepressants by 1.0%, and neuroleptics and other psychotropics by less than 1.0%. Hypnotics and anxiolytics were mostly used as a sleep disorder treatment. Antidepressants were taken appropriately for a depressive illness in only 44.1% of cases. Low doses of hypnotics and anxiolytics were found in about 10% of cases and low doses of antidepressants in 31.7% of cases. Subjects with a psychiatric disorder received a psychotropic treatment only infrequently (between 10% to 40.4%, depending on the disorder). All psychiatric disorders, including mood disorders, were treated mainly with an anxiolytic. A concomitant physical illness increased the likelihood of using a psychotropic treatment and was a strong predictor of adequate psychotropic dosage. CONCLUSION: Psychiatric pathology and sleep disorders remained mostly untreated or inadequately managed in the general population. Depression is underdiagnosed by the physicians and is treated with antidepressant in only 7% of cases. By contrast, anxiolytics are extensively prescribed, especially in France and Italy. The co-occurrence of organic and psychiatry disorders increases the frequency of medical consultations and the likelihood of being given a prescription for the mental disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“adding CBT was of limited value in one trial, 22 but facilitated discontinuation in other trials. 23,24”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [22]
In the citing paper
“a brief GP intervention based on gradual dose reduction, resulting in 3-12 months discontinuation rates of 51% and 45% respectively. 14,22”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [22]
In the citing paper
“The results of studies on such strategies have been inconsistent.”
From Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care (2014) · cites this paper as [22]
Citations
Cites
Still being checked.
Cited by
Items 201–271 of 271
Study protocol—Evoked craving in high-dose benzodiazepine users
Zamboni, L., Toldo, S., Fusina, F., Mattiello, M., Mannari, V., Campagnari, S., Schiavone, V., Congiu, A., Verlato, G., Chiamulera, C., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.956892 · Cited by 2
Drug utilization study in the department of psychiatry
kumarYerragopu, A., Anusha, V. L., Begum, S. S., & Rajesh, A. (2023) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2023.8.1.0119 · Cited by 2
Hypnotics and antihistamines : effects ono cognitive functions and driving performance
Vermeeren, A. (2003) · Research Publications (Maastricht University) · doi:10.26481/dis.20030509av · Cited by 2
LADER, M. H. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051992 · Cited by 2
Self-citationDrs. Laukkala and Colleagues Reply
Laukkala, T., Isometsä, E. T., HÄMÄLÄINEN, J., Heikkinen, M. E., Lindeman, S. M., & Aro, H. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.190 · Cited by 2
Antidepressant Usage in the Canadian Forces
Gutschi, L. M., Vaillancourt, R., & Boddam, R. (2006) · Military Medicine · doi:10.7205/milmed.171.2.107 · Cited by 2
Karjouh, K., Azzaoui, F.-Z., Ahami, A. O. T., & Boulbaroud, S. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.31.133.13425 · Cited by 2
Saadeh, N., Dargham, T. B., Talih, F., Ghanimé, P. M., Morad, B., Aboukhater, D., Ghadieh, J., Succar, F., & Ardakani, J. (2025) · Lebanese Journal of Mental Health · doi:10.4103/ljmh.ljmh_6_25 · Cited by 1
Profil de prescription des psychotropes dans un organisme de Sécurité sociale marocain
Belkacem, A., Omari, F., Khadri, J. E., Paes, M., & Ktiouet, J. E. (2006) · L Encéphale · doi:10.1016/s0013-7006(06)76161-9 · Cited by 1
Therapy of mental disorders in patients with hematological malignancies
Выборных, Д. Э., Иванов, С. В., Гемджян, Э. Г., Esina, L. V., & Гапонова, Т. В. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2024124041127 · Cited by 1
Substance Use Disorders: A Biopsychosocial Perspective
Duncan, P. M. (2020) · ODU Digital Commons (Old Dominion University) · Cited by 3
Kjosavik, S. R. (2012) · NORA - Norwegian Open Research Archives · Cited by 4
Reysset, A. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 3
Roose, S. P., & Pinder, R. M. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00094-4 · Cited by 1
Wake up to insomnia diagnosis: Asking the right questions of who, where, when, and what
Becker, P. M. (2009) · Sleep Medicine · doi:10.1016/j.sleep.2009.08.009 · Cited by 1
Baumann, M., & Spitz, É. (2007) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-2-21 · Cited by 1
Epidemiology of anxiolytic and hypnotic drug use in the general population in Norway
Hausken, A. M. (2010) · NORA - Norwegian Open Research Archives · Cited by 1
Shirama, F. H. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2018.tde-28112017-163739 · Cited by 1
Santé et insécurité routière : influence de la consommation de médicaments (Étude CESIR-A)
Orriols, L. (2010) · theses.fr (ABES) · doi:10.70675/c3fe1681zcd31z4f35zb0a1z782ddfc55d02 · Cited by 3
Aubron, V. (2009) · theses.fr (ABES) · doi:10.70675/8fbb35fcz7bd3z4135zb558z7b3cf87b63ac · Cited by 4
Siani-Morello, M. R. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2014.tde-30102014-163819 · Cited by 1
Vascular Heart and Brain Disease and Incident Late-Life Depression
Luijendijk, H. J. (2010) · RePub (Erasmus University Rotterdam)
Pavarin, R. M. (2007) · Epidemiology and Psychiatric Sciences · doi:10.1017/s1121189x00002530
Deflesselle, É. (2015) · HAL
Nebenwirkung Medikamentenmissbrauch : Lösungswege aus der Sackgasse?
Maffli, E. (2009) · E-Periodica · doi:10.5169/seals-800642
Berthelon, C., Meskali, M., Cocquerel, A., Moessinger, M., Bocca, M., Marie, S., & Denise, P. (2007)
Zahra, D., Ahami, A. O. T., Sanae, S., Samira, M., Belala, A., Harkati, F. B., & Bouchikh, K. (2017) · Neuroscience & Medicine · doi:10.4236/nm.2017.82002
Blaich, C., Thiem, H., & Potempa, C. (2017) · Gesundheitsökonomie & Qualitätsmanagement · doi:10.1055/s-0043-118820
Injuries Among Elderly Canadians: Psychotropic Medications and the Impact of Alcohol
Riley, N. M. (2012) · TSpace (University of Toronto)
Research report Treatment of anxiety disorders in the Finnish general population
Sihvo, S., Hämäläinen, J., Kiviruusu, O. H., Pirkola, S. P., & Isometsä, E. T. (2006)
de Paula, D. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2018.tde-29052018-155934
Ansseaua, M., Fischler, B., Dierick, M., Mignond, A., & Leymand, S. (2005) · European psychiatry (Ed Española) · doi:10.1017/s1134066500008936
Psychiatric Disorders, Personality, and Developmental Factors
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.009
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.015
Use Disorders of Cocaine and Methamphetamine
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.014
Tranquilizers and Sedative Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.016
Pérez, M. I. S. (2020) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/42726
Vrublevska, K., Jēkabsons, K., Rugaja, Z., Zīle, I., Svarcbahs, R., Kurlovičs, J., Afanasjeva, K., Ligere, R., Tarasevičius, E., & Muceniece, R. (2011)
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.018
Current Awareness in Human Psychopharmacology
(2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.458
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.001
The Biopsychosocial Perspective and Research Methods for Investigation of Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.002
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.010
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.004
Genetic Influence on Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.007
Brain Function and Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.006
Tobacco Use and Nicotine Addiction
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.012
Behavioral, Cognitive, and Social Factors Promoting SUD
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.008
Psychopharmacology: Drug Effects on Brain Function
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.005
Diagnosis of Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.003
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.011
Treatment of Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.017
Rebound with hypnotic medication
LADER, M. H. (2008) · CRC Press eBooks · doi:10.3109/9780203091715-13
Self-citationColucci-D’Amato, A., Annunziata, A., & Fiorentino, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-27968-3_6
Laforgue, E. (2022) · theses.fr (ABES) · doi:10.70675/5f37c364z133dz4d44zac24z22ca70ec1473
Webster, L. R. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780197517277.002.0009
Sveučilište u Zagrebu, M. F., Benčić, M., Herceg, M., Sveučilište u Zagrebu, M. F., Klinika za psihijatriju Vrapče, Z., Draganić, P., Sveučilište u Rijeci, F. B. I. R. L., & HALMED, A. Z. L. I. M. P. (2024) · Socijalna psihijatrija · doi:10.24869/spsih.2024.164
Use of analgesics and psychotropic medication: Findings from the Lolland- Falster Health StudyPreprint
Bruun-Rasmussen, N. E., Lophaven, S., Rasmussen, M. R., & Lynge, E. (2024) · Research Square · doi:10.21203/rs.3.rs-5694365/v1
Evoked craving in high-dose benzodiazepine users
Zamboni, L., Benvegnù, G., Fusina, F., Vesentini, R., Locatelli, F., Mattiello, M., Mannari, V., Campagnari, S., Toldo, S., Congiu, A., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1562622
Additional file 1 of Natural history in Malan syndrome: survey of 28 adults and literature review
Huynh, T. N., Delagrammatikas, C. G., Chiriatti, L., Panfili, A., Ventarola, K., Menke, L. A., Tartaglia, M., Huisman, S. A., & Priolo, M. (2024) · Figshare · doi:10.6084/m9.figshare.26401876
Additional file 2 of Natural history in Malan syndrome: survey of 28 adults and literature review
Huynh, T. N., Delagrammatikas, C. G., Chiriatti, L., Panfili, A., Ventarola, K., Menke, L. A., Tartaglia, M., Huisman, S. A., & Priolo, M. (2024) · Figshare · doi:10.6084/m9.figshare.26402021
Additional file 3 of Natural history in Malan syndrome: survey of 28 adults and literature review
Huynh, T. N., Delagrammatikas, C. G., Chiriatti, L., Panfili, A., Ventarola, K., Menke, L. A., Tartaglia, M., Huisman, S. A., & Priolo, M. (2024) · Figshare · doi:10.6084/m9.figshare.26755153
Besch, V. (2025) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:187339
Pharmacist interventions in depressed patients
Valera, M. R. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 4
Les déterminants de la prescription médicamenteuse en médecine générale
Darmon, D. (2014) · theses.fr (ABES) · doi:10.70675/978c23c9z46bdz4df7z82e5zcdd0b8237c93 · Cited by 2
Metadata
- Authors
- Ohayon, M. M., & Lader, M. H.
- Affiliations
- Stanford Medicine (US)
- ORCID
- Ohayon, Maurice M.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-09-15
- Volume
- 63
- Issue
- 9
- Pages
- 817-825
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2137401427
- Cited by
- 271
- References
- 0
- Citations by year
- 2025: 3 · 2024: 10 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 33 · 2019: 10 · 2018: 7 · 2017: 10 · 2016: 11 · 2015: 12 · 2014: 11 · 2013: 11 · 2012: 11
- FWCI
- 15.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- psychotropic drug use, anxiolytics, hypnotics, antidepressants, antipsychotic drugs, sleep disorders, underdiagnosis of depression, mental illness, prescribing patterns, general population
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Mental Disorders, Cross-Cultural Comparison, Drug Utilization, Expert Systems, Female, France, Germany, United Kingdom, Humans, Hypnotics and Sedatives, Italy, Male, Middle Aged, Practice Patterns, Physicians', Psychotropic Drugs, Sleep Wake Disorders, Anti-Anxiety Agents, Comorbidity, Logistic Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.